<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cyclooxygenase (Cox-2) is implicated in the pathogenesis of many <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> including esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (EAC), whereas the role of the isoform Cox-1 in <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> is not well understood </plain></SENT>
<SENT sid="1" pm="."><plain>To further elucidate the role of these factors in the development of EAC, we measured the gene expressions (<z:chebi fb="2" ids="33699">mRNA</z:chebi> levels) of Cox-2 and Cox-1 by real-time quantitative polymerase chain reaction (QRT-PCR) in tissues from <z:mpath ids='MPATH_458'>normal</z:mpath> esophagus with and without erosive <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>), <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE), <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, and in healthy gastric antrum </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> tissues were purified by laser capture microdissection from endoscopic or surgical resection specimens </plain></SENT>
<SENT sid="3" pm="."><plain>Median Cox-2 gene expression did not differ significantly among the esophageal control groups but was elevated 5-fold in BE, 8-fold in <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and 16-fold in EAC compared to <z:mpath ids='MPATH_458'>normal</z:mpath> esophageal controls with no erosive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Erosive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> tissue had slightly higher median Cox-2 expression but Cox-2 expression in <z:mpath ids='MPATH_458'>normal</z:mpath> antrum was much higher than that in a <z:mpath ids='MPATH_458'>normal</z:mpath> esophagus, close to that of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast to that of Cox-2, Cox-1 expression was significantly decreased in <z:hpo ids='HP_0000001'>all</z:hpo> neoplastic tissues compared to <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="6" pm="."><plain>Cox-1 and Cox-2 expression varied over a wide range in the neoplastic tissues but over a relatively narrow range in the esophageal <z:mpath ids='MPATH_458'>normal</z:mpath> tissues </plain></SENT>
<SENT sid="7" pm="."><plain>The occurrence of substantial alterations in Cox-1 and Cox-2 expression at the BE stage indicates that these are early events in the development of EAC </plain></SENT>
<SENT sid="8" pm="."><plain>These results confirm the important role of Cox-2 amplification in the pathogenesis of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, but the unexpected down-regulation of Cox-1 raises questions about its role in <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
</text></document>